The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Theraputics Inc (ACRS) | COM | 00461U105 | 456,178 | 434,455 | SH | SOLE | 434,455 | 0 | 0 | |||
| Atreca Inc. (BCEL) | CL A COM | 04965G109 | 51,170 | 387,653 | SH | SOLE | 387,653 | 0 | 0 | |||
| Avrobio, Inc. (AVRO) | COM | 05455M100 | 1,373,299 | 1,009,779 | SH | SOLE | 1,009,779 | 0 | 0 | |||
| Biomea Fusion Inc (BMEA) | COM | 09077A106 | 11,597,952 | 798,757 | SH | SOLE | 798,757 | 0 | 0 | |||
| BridgeBio Pharma Inc. (BBIO) | COM | 10806X102 | 244,970,206 | 6,068,125 | SH | SOLE | 6,068,125 | 0 | 0 | |||
| Compass Pathways Plc (CMPS) | SPONSORED ADS | 20451W101 | 8,439,000 | 964,500 | SH | SOLE | 964,500 | 0 | 0 | |||
| Elevation Oncology Inc (ELEV) | COM | 28623U101 | 1,522,347 | 2,834,910 | SH | SOLE | 2,834,910 | 0 | 0 | |||
| Marker Therapeutics, Inc. (MRKR) | COM | 57055L206 | 1,728,571 | 314,286 | SH | SOLE | 314,286 | 0 | 0 | |||
| Monte Rosa Therapeutics Inc (GLUE) | COM | 61225M102 | 8,318,670 | 1,472,331 | SH | SOLE | 1,472,331 | 0 | 0 | |||
| Nuvation Bio Inc. (NUVB) | COM CL A | 67080N101 | 3,836,924 | 2,541,009 | SH | SOLE | 2,541,009 | 0 | 0 | |||
| Poseida Therapeutics Inc. (PSTX) | COM | 73730P108 | 3,505,377 | 1,043,267 | SH | SOLE | 1,043,267 | 0 | 0 | |||
| Reneo Pharmaceuticals Inc (RPHM) | COM | 75974E103 | 1,417,720 | 886,075 | SH | SOLE | 886,075 | 0 | 0 | |||
| Spruce Biosciences, Inc. (SPRB) | COM | 85209E109 | 3,532,147 | 1,205,511 | SH | SOLE | 1,205,511 | 0 | 0 | |||
| Syndax Pharmaceuticals, Inc. (SNDX) | COM | 87164F105 | 22,150,250 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | |||
| Verona Pharma plc (VRNA) | SPONSORED ADS | 925050106 | 22,173,198 | 1,115,352 | SH | SOLE | 1,115,352 | 0 | 0 | |||
| Viracta Therapeutics Inc (VIRX) | COM | 92765F108 | 164,485 | 288,571 | SH | SOLE | 288,571 | 0 | 0 | |||